Ridgetech Inc.
Get $10 bonus on your first $100 deposit for RDGT
Get $10 bonus on your first $100 deposit for RDGT
Ridgetech Inc. (RDGT) Stock Competitors & Peer Comparison
See (RDGT) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RDGT | $0.02 | -37.05% | 144K | -0.07 | -$0.36 | N/A |
| MCK | $858.07 | -1.63% | 109.1B | 25.55 | $34.61 | +0.36% |
| COR | $318.14 | +0.15% | 63.2B | 39.09 | $8.31 | +0.71% |
| CAH | $211.90 | -0.06% | 50.4B | 30.80 | $6.95 | +0.95% |
| ABC | $179.98 | -0.23% | 36.1B | 21.92 | $8.21 | N/A |
| HSIC | $73.91 | +1.19% | 8.7B | 22.61 | $3.27 | N/A |
| PDCO | $31.33 | +0.00% | 2.8B | 20.48 | $1.53 | +1.66% |
| PBH | $52.33 | -9.28% | 2.5B | 13.85 | $3.79 | N/A |
| GRDN | $37.94 | +0.85% | 2.4B | 48.71 | $0.78 | N/A |
| OMI | $2.68 | +8.94% | 207.1M | -0.47 | -$5.69 | N/A |
Stock Comparison
RDGT vs MCK Comparison April 2026
RDGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 144K. In comparison, MCK has a market cap of 109.1B. Regarding current trading prices, RDGT is priced at $0.02, while MCK trades at $858.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.07, whereas MCK's P/E ratio is 25.55. In terms of profitability, RDGT's ROE is +0.42%, compared to MCK's ROE of -2.45%. Regarding short-term risk, RDGT is more volatile compared to MCK. This indicates potentially higher risk in terms of short-term price fluctuations for RDGT.Check MCK's competition here
RDGT vs COR Comparison April 2026
RDGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 144K. In comparison, COR has a market cap of 63.2B. Regarding current trading prices, RDGT is priced at $0.02, while COR trades at $318.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.07, whereas COR's P/E ratio is 39.09. In terms of profitability, RDGT's ROE is +0.42%, compared to COR's ROE of +1.01%. Regarding short-term risk, RDGT is more volatile compared to COR. This indicates potentially higher risk in terms of short-term price fluctuations for RDGT.Check COR's competition here
RDGT vs CAH Comparison April 2026
RDGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 144K. In comparison, CAH has a market cap of 50.4B. Regarding current trading prices, RDGT is priced at $0.02, while CAH trades at $211.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.07, whereas CAH's P/E ratio is 30.80. In terms of profitability, RDGT's ROE is +0.42%, compared to CAH's ROE of -0.59%. Regarding short-term risk, RDGT is more volatile compared to CAH. This indicates potentially higher risk in terms of short-term price fluctuations for RDGT.Check CAH's competition here
RDGT vs ABC Comparison April 2026
RDGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 144K. In comparison, ABC has a market cap of 36.1B. Regarding current trading prices, RDGT is priced at $0.02, while ABC trades at $179.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.07, whereas ABC's P/E ratio is 21.92. In terms of profitability, RDGT's ROE is +0.42%, compared to ABC's ROE of +1.01%. Regarding short-term risk, RDGT is more volatile compared to ABC. This indicates potentially higher risk in terms of short-term price fluctuations for RDGT.Check ABC's competition here
RDGT vs HSIC Comparison April 2026
RDGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 144K. In comparison, HSIC has a market cap of 8.7B. Regarding current trading prices, RDGT is priced at $0.02, while HSIC trades at $73.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.07, whereas HSIC's P/E ratio is 22.61. In terms of profitability, RDGT's ROE is +0.42%, compared to HSIC's ROE of +0.12%. Regarding short-term risk, RDGT is more volatile compared to HSIC. This indicates potentially higher risk in terms of short-term price fluctuations for RDGT.Check HSIC's competition here
RDGT vs PDCO Comparison April 2026
RDGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 144K. In comparison, PDCO has a market cap of 2.8B. Regarding current trading prices, RDGT is priced at $0.02, while PDCO trades at $31.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.07, whereas PDCO's P/E ratio is 20.48. In terms of profitability, RDGT's ROE is +0.42%, compared to PDCO's ROE of +0.06%. Regarding short-term risk, RDGT is more volatile compared to PDCO. This indicates potentially higher risk in terms of short-term price fluctuations for RDGT.Check PDCO's competition here
RDGT vs PBH Comparison April 2026
RDGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 144K. In comparison, PBH has a market cap of 2.5B. Regarding current trading prices, RDGT is priced at $0.02, while PBH trades at $52.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.07, whereas PBH's P/E ratio is 13.85. In terms of profitability, RDGT's ROE is +0.42%, compared to PBH's ROE of +0.10%. Regarding short-term risk, RDGT is more volatile compared to PBH. This indicates potentially higher risk in terms of short-term price fluctuations for RDGT.Check PBH's competition here
RDGT vs GRDN Comparison April 2026
RDGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 144K. In comparison, GRDN has a market cap of 2.4B. Regarding current trading prices, RDGT is priced at $0.02, while GRDN trades at $37.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.07, whereas GRDN's P/E ratio is 48.71. In terms of profitability, RDGT's ROE is +0.42%, compared to GRDN's ROE of +0.28%. Regarding short-term risk, RDGT is more volatile compared to GRDN. This indicates potentially higher risk in terms of short-term price fluctuations for RDGT.Check GRDN's competition here
RDGT vs OMI Comparison April 2026
RDGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 144K. In comparison, OMI has a market cap of 207.1M. Regarding current trading prices, RDGT is priced at $0.02, while OMI trades at $2.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.07, whereas OMI's P/E ratio is -0.47. In terms of profitability, RDGT's ROE is +0.42%, compared to OMI's ROE of +7.33%. Regarding short-term risk, RDGT is less volatile compared to OMI. This indicates potentially lower risk in terms of short-term price fluctuations for RDGT.Check OMI's competition here
RDGT vs ACH Comparison April 2026
RDGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 144K. In comparison, ACH has a market cap of 201M. Regarding current trading prices, RDGT is priced at $0.02, while ACH trades at $2.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.07, whereas ACH's P/E ratio is -1.96. In terms of profitability, RDGT's ROE is +0.42%, compared to ACH's ROE of +7.33%. Regarding short-term risk, RDGT is more volatile compared to ACH. This indicates potentially higher risk in terms of short-term price fluctuations for RDGT.Check ACH's competition here
RDGT vs HX Comparison April 2026
RDGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 144K. In comparison, HX has a market cap of 53.4M. Regarding current trading prices, RDGT is priced at $0.02, while HX trades at $2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.07, whereas HX's P/E ratio is -1.84. In terms of profitability, RDGT's ROE is +0.42%, compared to HX's ROE of -1.07%. Regarding short-term risk, RDGT is more volatile compared to HX. This indicates potentially higher risk in terms of short-term price fluctuations for RDGT.Check HX's competition here
RDGT vs GEG Comparison April 2026
RDGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 144K. In comparison, GEG has a market cap of 52.2M. Regarding current trading prices, RDGT is priced at $0.02, while GEG trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.07, whereas GEG's P/E ratio is -3.86. In terms of profitability, RDGT's ROE is +0.42%, compared to GEG's ROE of -0.21%. Regarding short-term risk, RDGT is more volatile compared to GEG. This indicates potentially higher risk in terms of short-term price fluctuations for RDGT.Check GEG's competition here
RDGT vs WGRX Comparison April 2026
RDGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 144K. In comparison, WGRX has a market cap of 7.2M. Regarding current trading prices, RDGT is priced at $0.02, while WGRX trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.07, whereas WGRX's P/E ratio is -0.07. In terms of profitability, RDGT's ROE is +0.42%, compared to WGRX's ROE of +1417.60%. Regarding short-term risk, RDGT is more volatile compared to WGRX. This indicates potentially higher risk in terms of short-term price fluctuations for RDGT.Check WGRX's competition here
RDGT vs SNYR Comparison April 2026
RDGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 144K. In comparison, SNYR has a market cap of 7.2M. Regarding current trading prices, RDGT is priced at $0.02, while SNYR trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.07, whereas SNYR's P/E ratio is -0.63. In terms of profitability, RDGT's ROE is +0.42%, compared to SNYR's ROE of +0.83%. Regarding short-term risk, RDGT is more volatile compared to SNYR. This indicates potentially higher risk in terms of short-term price fluctuations for RDGT.Check SNYR's competition here
RDGT vs ZYXI Comparison April 2026
RDGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 144K. In comparison, ZYXI has a market cap of 1.7M. Regarding current trading prices, RDGT is priced at $0.02, while ZYXI trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.07, whereas ZYXI's P/E ratio is -0.02. In terms of profitability, RDGT's ROE is +0.42%, compared to ZYXI's ROE of -18.07%. Regarding short-term risk, RDGT is less volatile compared to ZYXI. This indicates potentially lower risk in terms of short-term price fluctuations for RDGT.Check ZYXI's competition here
RDGT vs MEHA Comparison April 2026
RDGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 144K. In comparison, MEHA has a market cap of 1M. Regarding current trading prices, RDGT is priced at $0.02, while MEHA trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.07, whereas MEHA's P/E ratio is 14.70. In terms of profitability, RDGT's ROE is +0.42%, compared to MEHA's ROE of +1.19%. Regarding short-term risk, RDGT is more volatile compared to MEHA. This indicates potentially higher risk in terms of short-term price fluctuations for RDGT.Check MEHA's competition here
RDGT vs CVET Comparison April 2026
RDGT plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RDGT stands at 144K. In comparison, CVET has a market cap of 0. Regarding current trading prices, RDGT is priced at $0.02, while CVET trades at $20.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RDGT currently has a P/E ratio of -0.07, whereas CVET's P/E ratio is -69.97. In terms of profitability, RDGT's ROE is +0.42%, compared to CVET's ROE of -0.06%. Regarding short-term risk, RDGT is more volatile compared to CVET. This indicates potentially higher risk in terms of short-term price fluctuations for RDGT.Check CVET's competition here